SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...

Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while ...

95% CI 1.07 to 1.43), but a similar risk for myocardial infarction (MI) compared with the reference group. Patients with T1MI had a lower adjusted risk of death (0.86, 95% CI 0.74 to 1.00) and higher ...

Based on 2015 Medicare physician reimbursement rate, a single vessel CTO PCI is reimbursed at the same rate as a single vessel non-CTO PCI for acute myocardial infarction [44]. A CTO PCI is an ...

Ventricular tachycardia is an abnormally fast heart beat (with three or more consecutive heart beats at least 100 beats per minute) that originates from one of the ventricles in the heart. The ...